Article
Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database.
International journal of clinical oncology - 1 Jul 2026
Kawauchi Daisuke, Ohno Makoto, Takahashi Masamichi, Koyama Takafumi, Sunami Kuniko, Hirata Makoto, Yanagisawa Shunsuke, Omura Takaki, Aoki Takuma, Fujii Genta, Saito Koji, Yamamoto Tetsuya, Suzuki Hiromichi, Narita Yoshitaka
Abstract excerpt
BACKGROUND: Comprehensive genomic profiling test (CGPT) using next-generation sequencing (NGS) plays a vital role in cancer diagnosis, treatment option, and prognostic evaluation. In Japan, three tissue-based CGPTs, FoundationOne® CDx, GenMineTOP, and NCC OncoGuide™, are reimbursed under public health insurance. However, their comparative performance in central nervous system (CNS) tumors remains unclear....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
